GNH USA

Europe — EMA

Olmesartan Medoxomil Teva

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil Teva, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is used to treat hypertension in adults.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil Teva, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is used to treat hypertension in adults. GNH USA supplies Olmesartan Medoxil Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxil Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan Medoxil is an ARB that lowers blood pressure by blocking the effects of angiotensin II.

- Hypertension: Reduces systolic and diastolic blood pressure, helping to prevent cardiovascular events. - Heart failure: Improves cardiac output and reduces fluid retention when used with other heart‑failure therapies. - Diabetic nephropathy: Slows the progression of kidney damage associated with type 2 diabetes. - Post‑myocardial infarction: Lowers the risk of recurrent heart attacks by controlling blood pressure. - Stroke prevention: Contributes to secondary prevention of ischemic stroke in high‑risk patients. - Chronic kidney disease: Helps preserve renal function by reducing intraglomerular pressure.

What are the side effects of Olmesartan Medoxomil?

Olmesartan Medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness or light‑headed ​d​ ​at ​onset ​of ​treatment  - Headache  - Fatigue  - Nasal congestion  - Diarrhoea  - Cough 

Serious or Rare Side Effects: - Angio‑ang              -  ang   - Hyper‑kalemia  - Acute kidney injury  - Severe hypotension  - Liver enzyme elevation  - Allergic skin reactions (e.g., Stevens‑Johnson syndrome).

What precautions apply to Olmesartan Medoxomil?

Olmesartan Medoxil requires careful monitoring in several clinical situations.

- Renal impairment: Adjust dosage based on kidney function and monitor serum creatinine. - Hepatic impairment: Use with caution; monitor liver enzymes. - Electrolyte disturbances: Watch for hyper‑kalemia, especially with potassium‑sparing diuretics. - Pregnancy             -                   - Breast          "); -     ");   - Store       ");  "); "  " " " " " " " " "  - ");  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil
Route
Oral Use
Manufacturer
Teva B.V
Origin
EU

Related products